News Releases 2024
-
Personnel
Announcement of Personnel Change of the Mitsubishi Chemical GroupNEW
-
Others
Main building of Mitsubishi Chemical Group's Science & Innovation Center receives WELL Building Standard v2 pilot certificationNEW
-
Business
Announcement of Publication in The Lancet Neurology from the Clinical Study of Investigational ND0612 for Parkinson's DiseaseNEW
-
Business
Nichigo G-Polymer, a special brand of polyvinyl alcohol, certified as a recyclable material for polyethylene-based multilayer packaging materials in EuropeNEW
-
Business
Additional Approval of SGLT2 inhibitor CANAGLU® OD Tablets~First OD Tablets of SGLT2 inhibitors in Japan~NEW
-
Business
Launch of "GOBIK Aqueous Suspension Syringes", Pertussis, Diphtheria, Tetanus, Inactivated Polio and Hib Combined Vaccine
-
Business
Mitsubishi Chemical Group announces the Winner of the 3D Printing FGF Engineering Challenge
-
Others
Notice Concerning Change of Major Shareholder
-
Business
Mitsubishi Chemical Group Develops BiOpreg #400 Series Carbon Fiber Prepreg Using Plant-Derived Resin
-
Business
Expiration of Marketing Alliance Agreement for TENELIA® Tablets, TENELIA® OD Tablets and CANAGLU® Tablets
-
Business
Mitsubishi Chemical Group to increase Sugar Ester emulsifier production capacity
Will add new line to Kyushu Plant to meet global demand for high-quality food products -
Personnel
Announcement of Organizational Changes and Personnel Changes of the Mitsubishi Chemical Group
-
Business
Announcement on the Discontinuance of MMA Production by the ACH Process and Acrylonitrile-Related Production at the Hiroshima Plant, and on Subsequent Withdrawal from Some Businesses
-
Business
Launch of Radicava® for the Treatment of ALS in Brazil~First successful launch by a partner in global expansion~
-
Personnel
Notice Regarding Change (Appointed) of Representative Corporate Executive Officer
-
Business
Application for Additional Dosage Form of CANALIA® Combination OD Tablets, Selective DPP-4 inhibitor/SGLT2 inhibitor Combination Drug
-
Business
Mitsubishi Chemical Group Develops Carbon Fiber-based 1,500 °C Heat-Resistant Ceramic Matrix Composite (C/SiC)
-
Business
Plant-derived bioengineering plastic DURABIO used in Sunstar’s Ora2 Toothbrush
-
Others
Signed a Comprehensive Collaboration Agreement with Fukui Prefecture to Build a Sustainable Society
-
Business
Newly Developed Biodegradable Biopolyester Resins
- High biomass content, flexibility, high tear strength, and excellent processability -
-
Personnel
Announcement of Organizational Changes and Personnel Changes of the Mitsubishi Chemical Group
-
Personnel
Notice Regarding Change (Retirement) of Representative Corporate Executive Officer
-
Business
Developed “NOVADURAN ZR Series” Foaming Polybutylene Terephthalate Resin
- Enables the production of molded products with ultra-low specific gravity less than 1.0 in a simple process -
-
Financial Results
Consolidated Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2024 (Under IFRS)
-
Business
Transfer of Three Marketed Products in Japan
-
Business
Mitsubishi Chemical Group to Commence Full-fledged Verification Testing for the World’s First Commercialization of Polycarbonate Resin Chemical Recycling
Conducting testing for collecting polycarbonate resin from headlamps of end-of-life vehicles in collaboration with Tokio Marine & Nichido and ABT
-
Business
Mitsubishi Tanabe Pharma contribute funding to Global Health Innovative Technology Fund's third phase ―Targeting treatments for infectious diseases that burden the developing world―
-
Business
Plant-derived Bioengineering Plastic DURABIO Selected by Panasonic for Wireless Earphones
-
Business
Co-promotion of "GOBIK Aqueous Suspension Syringes", Pertussis, Diphtheria, Tetanus, Inactivated Polio and Hib Combined Vaccine
-
Others
New Year Message from President and CEO, Jean-Marc Gilson (summary)